{{Template:UiOslo_Norway/Head}}
{{Template:UiOslo_Norway/Header}}
{{Template:UiOslo_Norway/TopBar}}
<html>
<head>
  <style>
  .front {
  display: block;
  margin-left: auto;
  margin-right: auto;
  width: 60%;
  margin-top: 10px;
  }

  p {
    text-align: justify;
  }
  </style>
</head>

<div class="container">
<h1>Experiments</h1>

<h3>
    Disclaimer
</h3>
<p>Due to restrictions imposed by the COVID-19 situation we were unable to perform any experiments. Protocols herein will be an indication of what we would aim to do if we had access to laboratories.</p>


<p>
  <strong>Goal:</strong>
  </p>
  <p>
  The goal of our synthetic biology plan was to engineer <em>E. coli</em> to produce salinomycin and then process salinomycin to produce narasin, an antiparasitic compound. This would complement our early detection system for amoebic gill disease (AGD) with a treatment option that is less harmful for fish in early steps of AGD. Our first step would be to clone the LuxR- family transcriptional regulator, SlnR into <em>E. coli</em> cells.
  </p>
  <p>
  We were inspired by these articles with regards to planning and materials:
  </p>
  
  <table>
    <tr>
    <td>SlnR is a positive pathway-specific regulator for salinomycin biosynthesis in Streptomyces albus. <a href="https://link.springer.com/article/10.1007/s00253-016-7918-5">Zhu et al 2016</a>
    </td>
    </tr>
    <tr>
    <td>Sigma factor WhiGch positively regulates natamycin production in Streptomyces chattanoogensis L10. <a href="https://link.springer.com/article/10.1007%2Fs00253-014-6307-1">Liu et al 2015</a>
    </td>
    </tr>
  </table>
  
  
  <p>
  <strong>How would we reach that goal?</strong>
  </p>
  <p>
  Our plan would be to clone the salinomycin producing gene cluster from <em>Streptomyces Albus</em> into <em>E. coli</em>. Since salinomycin targets gram-positive bacteria, the gram-negative <em>E. coli </em>is a good candidate for salinomycin production. Our first steps would be to isolate SlnR from  <em>Streptomyces Albus </em>gDNA ( protocols 1.1 -1.6). We would then clone it into a pBAD/His A expression vector and transform it with chemically induced <em>E. coli</em> cells (protocols 2.1 - 3.1).
  </p>
  <p>
  We would then aim to verify successful transformation via colony PCR, sequencing of transformants (protocols 3.2 - 3.4). To verify functional insert we would perform expression and purification of protein of interest and electrophoretic mobility shift assay (protocols 4.1 - 4.2)
  </p>
  <p>
  </p>
  <p>
  #### Legg til references 
  </p>
  <p>
  SlnR is a positive pathway-specific regulator for salinomycin biosynthesis in Streptomyces albus
  </p>
  <p>
  <a href="https://link.springer.com/article/10.1007/s00253-016-7918-5">https://link.springer.com/article/10.1007/s00253-016-7918-5</a>
  </p>
  <p>
  Sigma factor WhiGch positively regulates natamycin production in Streptomyces chattanoogensis L10. 
  </p>
  <p>
  <a href="https://link.springer.com/article/10.1007%2Fs00253-014-6307-1">https://link.springer.com/article/10.1007%2Fs00253-014-6307-1</a>
  </p>




<h2>Protocols</h2>
<p>Click to view our protocols in PDF-format.</p>

<ul>
  <li><a href="https://2020.igem.org/wiki/images/0/00/T--UiOslo_Norway--1.1_Isolation_of_gDNA_from_Streptomyces_albus.pdf"
    >1.1 Isolation of gDNA from Streptomyces albus</a></li>
  <li><a href="https://2020.igem.org/wiki/images/c/cd/T--UiOslo_Norway--1.2_Amplification_of_SlnR_from_Streptomyces_albus_gDNA.pdf
    ">1.2 Amplification of SlnR from Streptomyces albus gDNA</a></li>
  <li><a href="https://2020.igem.org/wiki/images/9/90/T--UiOslo_Norway--1.3_PCR_purification_via_QIAGEN_PCR_cleanup.pdf
    ">1.3 PCR purification via QIAGEN PCR cleanup</a></li>
  <li><a href="https://2020.igem.org/wiki/images/7/73/T--UiOslo_Norway--1.4_Miniprep_of_pBAD_His_from_bacterial_strain.pdf
    ">1.4 Miniprep of pBAD_His from bacterial strain</a></li>
  <li><a href="https://2020.igem.org/wiki/images/5/5a/T--UiOslo_Norway--1.5_Amplification_of_pBAD_His_vector_via_Phusion_PCR.pdf
    ">1.5 Amplification of pBAD_His vector via Phusion PCR
</a></li>
  <li><a href="https://2020.igem.org/wiki/images/d/d6/T--UiOslo_Norway--1.6_DpnI_Digestion.pdf
    ">1.6 DpnI Digestion</a></li>
  <li><a href="https://2020.igem.org/wiki/images/f/f7/T--UiOslo_Norway--2.1_Gibson_assembly_of_vector_and_amplified_insert.pdf
    ">2.1 Gibson assembly of vector and amplified insert</a></li>
  <li><a href="https://2020.igem.org/wiki/images/a/a5/T--UiOslo_Norway--2.2_Preparing_chemically_competent_DH5%CE%B1_cells.pdf
    ">2.2 Preparing chemically competent DH5α cells
</a></li>
  <li><a href="https://2020.igem.org/wiki/images/e/e6/T--UiOslo_Norway--3.1_Transformation_of_chemically_competent_cells.pdf
    ">3.1 Transformation of chemically competent cells
</a></li>
  <li><a href="https://2020.igem.org/wiki/images/9/9f/T--UiOslo_Norway--3.2_Verifying_cloning_with_colony_PCR.pdf"
    >3.2 Verifying cloning with colony PCR</a></li>
  <li><a href="https://2020.igem.org/wiki/images/5/5a/T--UiOslo_Norway--f3.3_Extraction_of_plasmid_DNA_from_DH5%CE%B1_cells_using_QIAprep_Spin_Miniprep_Kit.pdf
    ">3.3 Extraction of plasmid DNA from DH5α cells using QIAprep Spin Miniprep Kit
</a></li>
  <li><a href="https://2020.igem.org/wiki/images/4/4e/T--UiOslo_Norway--3.4_Verification_of_insert_via_sequencing_of_transformants.pdf
    ">3.4 Verification of insert via sequencing of transformants
</a></li>
  <li><a href="https://2020.igem.org/wiki/images/f/f0/T--UiOslo_Norway--4.1_Expression_and_purification_of_protein_of_interest.pdf
    ">4.1 Expression and purification of protein of interest
</a></li>
  <li><a href="https://2020.igem.org/wiki/images/8/82/T--UiOslo_Norway--4.2_Electrophoretic_mobility_shift_assay_.pdf
    ">4.2 Electrophoretic mobility shift assay </a></li>
</div>

</html>